188
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

The role of lncRNA SNHG14 in gastric cancer: enhancing tumor cell proliferation and migration, and mechanisms of CDH2 expression

, , , &
Pages 2522-2537 | Received 31 Jan 2023, Accepted 26 Nov 2023, Published online: 09 Jan 2024

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. 10.3322/caac.21660
  • Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409–436. 10.3322/caac.21731
  • Haque E, Esmail A, Muhsen I, et al. Recent trends and advancements in the diagnosis and management of gastric cancer. Cancers (Basel). 2022;14(22):5615.
  • Choi S, Park S, Kim H, et al. Gastric cancer: mechanisms, biomarkers, and therapeutic approaches. Biomedicines. 2022;10(3):543.
  • Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020;396(10251):635–648. 10.1016/S0140-6736(20)31288-5
  • Stubbs JD, Lekutis C, Singer KL, et al. cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences. Proc Natl Acad Sci U S A. 1990;87(21):8417–8421. 10.1073/pnas.87.21.8417
  • Larocca D, Peterson JA, Urrea R, et al. A Mr 46,000 human milk fat globule protein that is highly expressed in human breast tumors contains factor VIII-like domains. Cancer Res. 1991;51(18):4994–4998.
  • Carrascosa C, Obula RG, Missiaglia E, et al. MFG-E8/lactadherin regulates cyclins D1/D3 expression and enhances the tumorigenic potential of mammary epithelial cells. Oncogene. 2012;31(12):1521–1532.10.1038/onc.2011.356
  • Jinushi M, Nakazaki Y, Carrasco DR, et al. Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment. Cancer Res. 2008;68(21):8889–8898. 10.1158/0008-5472.CAN-08-2147
  • Tibaldi L, Leyman S, Nicolas A, et al. New blocking antibodies impede adhesion, migration and survival of ovarian cancer cells, highlighting MFGE8 as a potential therapeutic target of human ovarian carcinoma. PLoS One. 2013;8(8):e72708. doi: 10.1371/journal.pone.0072708
  • Hon CC, Ramilowski JA, Harshbarger J, et al. An atlas of human long non-coding RNAs with accurate 5’ ends. Nature. 2017;543(7644):7644):199–204.
  • Ye J, Li J, Zhao P. Roles of ncRNAs as ceRNAs in Gastric Cancer. Genes (Basel). 2021;12(7):1036.
  • Chen D, Ping S, Xu Y, et al. Non-Coding RNAs in gastric cancer: from malignant hallmarks to clinical applications. Front Cell Dev Biol. 2021;9(732036):1–13. doi: 10.3389/fcell.2021.732036
  • Wang GF, Wen LN. LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p. Eur Rev Med Pharmacol Sci. 2020;24(20):10410–10418.
  • Zhao JL, Wang CL, Liu YL, et al. Long noncoding RNA SNHG14 enhances migration and invasion of ovarian cancer by upregulating DGCR8. Eur Rev Med Pharmacol Sci. 2019;23(23):10226–10233.
  • Deng PC, Chen WB, Cai HH, et al. LncRNA SNHG14 potentiates pancreatic cancer progression via modulation of annexin A2 expression by acting as a competing endogenous RNA for miR-613. J Cell Mol Med. 2019;23(11):7222–7232. 10.1111/jcmm.14467
  • Lim H, Yang T, Lee W, et al. TGF-beta Increases MFGE8 production in myeloid-derived suppressor cells to promote b16f10 melanoma metastasis. Biomedicines. 2021;9(8):896.
  • Yang Y, Li J, Song Q, et al. Reduction in milk fat globule-EGF factor 8 inhibits triple-negative breast cancer cell viability and migration. Oncol Lett. 2019;17(3):3457–3465.
  • Sexton RE, Al Hallak MN, Diab M, et al. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39(4):1179–1203.10.1007/s10555-020-09925-3
  • Wang F, Wei XL, Wang FH, et al. Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432. Ann Oncol. 2019;30(9):1479–1486. 10.1093/annonc/mdz197
  • Machlowska J, Baj J, Sitarz M, et al. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012.
  • Ohtsu A, Ajani JA, Bai YX, et al. Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study. J Clin Oncol. 2013;31(31):3935–3943. 10.1200/JCO.2012.48.3552
  • Ramanathan RK, McDonough SL, Kennecke HF, et al. Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: a SWOG cooperative group trial (S1005). Cancer. 2015 Jul 1;121(13):2193–2197. doi: 10.1002/cncr.29363. Epub 2015 Mar 30. PMID: 25827820; PMCID: PMC4589423
  • Collins C, Nehlin JO, Stubbs JD, et al. Mapping of a newly discovered human gene homologous to the apoptosis associated-murine mammary protein, MFG-E8, to chromosome 15q25. Genomics. 1997;39(1):117–118.
  • Aziz M, Jacob A, Matsuda A, et al. Review: milk fat globule-EGF factor 8 expression, function and plausible signal transduction in resolving inflammation. Apoptosis. 2011;16(11):1077–1086.10.1007/s10495-011-0630-0
  • Hanayama R, Tanaka M, Miwa K, et al. Identification of a factor that links apoptotic cells to phagocytes. Nature. 2002;417(6885):182–187.10.1038/417182a
  • Deroide N, Li X, Lerouet D, et al. MFGE8 inhibits inflammasome-induced IL-1beta production and limits postischemic cerebral injury. J Clin Invest. 2013;123(3):1176–1181.
  • Silvestre JS, Thery C, Hamard G, et al. Lactadherin promotes VEGF-dependent neovascularization. Nat Med. 2005;11(5):499–506.10.1038/nm1233
  • Zhang L, Tian R, Yao X, et al. Milk fat globule-epidermal growth factor-factor 8 improves hepatic steatosis and inflammation. Hepatology. 2021;73(2):586–605.
  • Sugano G, Bernard-Pierrot I, Lae M, et al. Milk fat globule–epidermal growth factor–factor VIII (MFGE8)/lactadherin promotes bladder tumor development. Oncogene. 2011;30(6):642–653.
  • Avgerinos KI, Spyrou N, Mantzoros CS, et al. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism. 2019;92:121–135.10.1016/j.metabol.2018.11.001
  • Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–5667.10.1038/onc.2017.184
  • Tan YT, Lin JF, Li T, et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond). 2021;41(2):109–120.
  • Zhao L, Liu Y, Zhang J, et al. LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint. Cell Death Dis. 2019;10(10):731.10.1038/s41419-019-1886-5
  • Pu J, Wei H, Tan C, et al. Long noncoding RNA SNHG14 facilitates hepatocellular carcinoma progression through regulating miR-4673/SOCS1. Am J Transl Res. 2019;11(9):5897–5904.
  • Tang SJ, Yang JB. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma. Mol Cell Biochem. 2020;473(1–2):143–153.10.1007/s11010-020-03815-6
  • Liao Z, Zhang H, Su C, et al. Long noncoding RNA SNHG14 promotes hepatocellular carcinoma progression by regulating miR-876-5p/SSR2 axis. J Exp Clin Cancer Res. 2021;40(1):36.10.1186/s13046-021-01838-5
  • Liu G, Ye Z, Zhao X, et al. SP1-induced up-regulation of lncRNA SNHG14 as a ceRNA promotes migration and invasion of clear cell renal cell carcinoma by regulating N-WASP. Am J Cancer Res. 2017;7(12):2515–2525.
  • Wang Q, Teng Y, Wang R, et al. The long non-coding RNA SNHG14 inhibits cell proliferation and invasion and promotes apoptosis by sponging miR-92a-3p in glioma. Oncotarget. 2018;9(15):12112–12124.10.18632/oncotarget.23960
  • Brabletz T, Jung A, Reu S, et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A. 2001;98(18):10356–10361.
  • Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212–226. 10.1016/j.tcb.2018.12.001
  • Di W, Weinan X, Xin L, et al. Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7. Cell Death Dis. 2019;10(7):514.10.1038/s41419-019-1707-x
  • Yu H, Zhang C, Li W, et al. Nano-Coated si-SNHG14 Regulated PD-L1 expression and decreased epithelial-mesenchymal transition in nasopharyngeal carcinoma cells. J Biomed Nanotechnol. 2021;17(10):1993–2002.10.1166/jbn.2021.3162

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.